Physician profile
Eunice E Kim
NPI 1245468099
$1,240.00
in general payments reported to CMS, 2019-2025
16 companies · $91.34 in 2025
The $91.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2022: $18.15 · 2025: $91.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $244.49 | 2019 | |
| Pfizer INC. | $193.91 | 2019 | |
| Merck Sharp & Dohme LLC | $164.09 | 2019 | |
| Abbvie INC. | $111.64 | 2019 | |
| Inspire Medical Systems, INC. | $91.34 | 2025 | Inspire |
| Lilly USA, LLC | $80.75 | 2019 | |
| Gilead Sciences, INC. | $78.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.06 | 2019 | |
| Amgen INC. | $52.82 | 2019 | |
| Allergan, INC. | $45.48 | 2019 | |
| Novo Nordisk INC | $39.87 | 2019 | |
| Indivior INC. | $18.15 | 2022 | |
| Radius Health, INC. | $13.58 | 2019 | |
| Glaxosmithkline, LLC. | $12.23 | 2019 | |
| Metuchen Pharmaceuticals | $11.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunice Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.